AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Sucrazide MF 80mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Anthem Biopharma

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Sucrazide MF 80mg/500mg Tablet SR

Diabetase MF 80mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabetase MF should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with well-managed blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan, incorporating diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly influence diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Carry a readily available fast-acting glucose source (e.g., sugary snacks, juice) to counter hypoglycemia. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Sucrazide MF 80mg/500mg Tablet SR

Adult-onset diabetes

Major Benefits of Sucrazide MF 80mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Sucrazide MF 80mg/500mg Tablet SR with a meal.

Common Side effects of Sucrazide MF 80mg/500mg Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Sucrazide MF 80mg/500mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Sucrazide MF 80mg/500mg Extended-Release tablets with a meal.

How Sucrazide MF 80mg/500mg Tablet SR works:

The extended-release tablet, Sucrazide MF 80mg/500mg, combines the antidiabetic agents gliclazide and metformin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Sucrazide MF 80mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sucrazide MF 80mg/500mg sustained-release tablets is contraindicated in pregnancy due to demonstrable fetal risk. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Sucrazide MF 80mg/500mg tablet may pose a risk to breastfeeding infants. Available human data indicate potential transfer to breast milk with possible harm to the nursing child.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sucrazide MF 80mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Sucrazide MF 80mg/500mg SR tablets. Physician consultation is advised. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Sucrazide MF 80mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Medical advice is essential. Low initial doses are typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Sucrazide MF 80mg/500mg Tablet SR :

Should you forget a Sucrazide MF 80mg/500mg Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sucrazide MF 80mg/500mg Tablet SR

LabelValue
Addictive None.
Medication Classification Medication for diabetes

FAQs on Sucrazide MF 80mg/500mg Tablet SR

The extended-release tablet Sucrazide MF 80mg/500mg combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. This dual-action therapy, used in conjunction with a healthy diet and exercise, regulates blood glucose. Gliclazide stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose production and enhances insulin responsiveness. This formulation is unsuitable for type 1 diabetes.
Sucrazide MF 80mg/500mg sustained-release tablets are linked to several common adverse reactions. These include low blood sugar (hypoglycemia), changes in taste perception, nausea, abdominal discomfort, diarrhea, headaches, and upper respiratory infections. While infrequent, serious side effects such as lactic acidosis can occur. Prolonged treatment may also result in vitamin B12 deficiency.
Indeed, Sucrazide MF 80mg/500mg SR tablets may induce hypoglycemia. Low blood sugar manifests as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. This risk increases with skipped or delayed meals, alcohol consumption, strenuous physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is recommended.
Sucrazide MF 80mg/500mg Tablet SR use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this is a rare but potential complication of metformin. It's contraindicated in individuals with pre-existing kidney impairment, the elderly, and those consuming significant alcohol. Lactic acidosis symptoms may manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, queasiness, vomiting, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Sucrazide MF 80mg/500mg Tablet SR and seek immediate medical attention.
Prolonged use of Sucrazide MF 80mg/500mg sustained-release tablets can lead to vitamin B12 deficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Untreated deficiency may result in anemia, neurological issues such as tingling, numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at a minimum of once annually, has been proposed by some investigators.
Patients with hypersensitivity to Sucrazide MF 80mg/500mg Tablet SR components or inactive ingredients should not take this medication. Its use is contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Sucrazide MF 80mg/500mg Tablet SR and alcohol is unsafe. Alcohol consumption can exacerbate hypoglycemia and raise the risk of lactic acidosis.
The extended-release tablet Sucrazide MF 80mg/500mg combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances blood sugar control when coupled with a balanced diet and regular physical activity. Gliclazide stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for type 1 diabetes.
Sucrazide MF 80mg/500mg sustained-release tablets may cause common adverse reactions such as low blood glucose, taste disturbances, nausea, abdominal discomfort, loose stools, headache, and upper respiratory infections. Rare but potentially severe side effects, including lactic acidosis, are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Indeed, Sucrazide MF 80mg/500mg SR tablets may induce hypoglycemia. Low blood sugar can manifest as nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is advisable.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential adverse effect of Sucrazide MF 80mg/500mg Tablet SR. Also termed Metformin-associated lactic acidosis (MALA), this rare complication is linked to metformin use. Its occurrence is minimized by avoiding use in individuals with compromised kidney function, the elderly, and those who consume excessive alcohol. Potential indicators include muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal pain, or bradycardia. Should these symptoms develop, discontinue Sucrazide MF 80mg/500mg Tablet SR immediately and seek urgent medical attention.
Prolonged use of Sucrazide MF 80mg/500mg sustained-release tablets can lead to vitamin B12 deficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Untreated deficiency may result in anemia, neurological issues, including tingling and numbness in the extremities, weakness, urinary dysfunction, cognitive changes, and impaired balance. To mitigate these risks, supplemental vitamin B12 is recommended annually by some experts.
Patients with a history of hypersensitivity to Sucrazide MF 80mg/500mg Tablet SR components or inactive ingredients should not take this medication. Its use is also contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol concurrently with Sucrazide MF 80mg/500mg Tablet SR is inadvisable. This combination may reduce blood glucose to dangerously low levels (hypoglycemia) and heighten the risk of lactic acidosis.
Sucrazide MF 80mg/500mg T...
73
MRP 89
17% off